 In the case of estradiol/levonorgestrel, detailed ePRO data on bleeding/spotting from a one-year clinical trial are presented in the patient information leaflet.As well as clinical trial use, ePRO methods may be used to support patients in regular care.An example of this is the collection of symptom data from patients undergoing chemotherapy, using handheld diaries.